25(OH)D, 25-hydroxyvitamin D; BCS, body condition score; CaPP, calcium × phosphorus product; CKD, chronic kidney disease; CKD-MBD, chronic kidney diseasemineral and bone disorders; FGF-23, fibroblast growth factor-23; iCa, ionized calcium; IRIS, International Renal Interest Society; MCS, muscle condition score; PTH, parathyroid hormone; RC, reference cut-off; RHPT, renal secondary hyperparathyroidism; UPC, urine protein:creatinine ratio FGF-23 concentrations are an independent predictor of mortality. [6] [7] [8] Additionally, in people, increased PTH and decreased 25(OH)D concentrations are associated with decreased duration of survival. 6, 7 Other clinical variables correlated with survival in either people, cats, or dogs with CKD include hematocrit, body condition score (BCS), muscle condition score (MCS), albumin, creatinine, phosphorus, calcium × phosphorus product (CaPP), and urine protein:creatinine (UPC) ratio. [9] [10] [11] [12] [13] [14] [15] The primary aim of this study was to determine which markers of After inclusion into the study, all dogs were followed serially by phone contact, with either the owner, the primary care veterinarian, or both, until reaching study endpoint (all-cause death) or conclusion of the observational study period in March of 2017. Treatments, monitoring, and reason for euthanasia were not controlled during the study period and left to the discretion of the attending clinician and owners based on results of individual canine assessments and clinicopathologic results.
| MATERIALS AND METHODS

Client
| STATISTICAL ANALYSIS
Data were tested for normality using the Shapiro Wilk test and presented as either mean with SD or median and range. Survival times using all-cause death were calculated from the date of study enrollment to the date of death or euthanasia. Enrollment was recorded as the date on which the second documentation of necessary inclusion criteria was obtained. Dogs alive at conclusion of the study were cen- MCS included all cases of mild, moderate, and severe atrophy. Cut-off points were based on biologically relevant cut points or results generated from healthy dogs for this study. 4, 5 Log-rank test was used to determine if the survival curves were significantly different. Adjusted risk estimates for all-cause mortality were calculated using univariable Cox regression.
| RESULTS
Twenty-seven dogs were included in the survival analysis. Breeds included mixed breed dogs (n = 9), Labrador Retrievers (n = 2), Cocker Spaniels (n = 2), Shetland Sheepdogs (n = 2), and one of each of the following: Boxer, Fox Terrier, German Shepherd Dog, Greyhound, Jack
Russell Terrier, Miniature Schnauzer, Pekingese, Pomeranian, Shih Tzu, Viszla, and Whippet. Thirteen dogs were females (all spayed) and 14 dogs were males (1 entire, 13 neutered).
Complete descriptive data have been previously published on this study population. 4, 5 Variables of interest that were used in the survival analysis are reported in Table 2 .
Kaplan-Meier survival curves were significantly different based on increased plasma FGF-23 concentration (P < .05), total hypocalcemia (P = .001), hypoalbuminemia (P < .01), increasing CKD stage (P = .01), hyperphosphatemia (P = .05), increased CaPP >70
(P = .003), and proteinuria (P = .01; Figures 1 and 3 ). Decreased BCS (P = .05) and MCS (P = .01) were both significantly associated with reduced survival (Figure 2 ). Dogs had significantly increased case fatality rate (P = .01) with each increase in IRIS stage.
Decreased hematocrit (P = .94), ionized hypocalcemia (P = .72), were not associated with survival ( Figure 3 ). concentrations did not result in significant hazard ratios in this study.
Hazard ratios for these variables are reported in Table 2 .
| DISCUSSION
This study examined variables, including plasma FGF-23, that were associated with survival time in dogs with azotemic CKD. Increased plasma FGF-23 concentration, proteinuria, hyperphosphatemia, total hypocalcemia, hypoalbuminemia, decreased BCS, decreased MCS, increased CaPP, and advanced CKD stage were all associated with being a risk factor for all-cause death in a population of dogs with azotemic CKD. These results are similar to findings in a study of CKD in cats. 8 None of the other variables examined, including hematocrit, iCa, serum PTH, 25(OH)D, and 1,25(OH) 2 D concentrations were found to be associated with survival time using all-cause death. This is in contrast to other reports where these factors have been associated with a worse prognosis in people with CKD. 6, 7, 10, 13 The univariable analysis is consistent with previous reports in cats and people. [17] [18] [19] [20] [21] Importantly, this is the first report of an association between FGF-23 and all-cause death in dogs. It has been proposed that FGF-23 is a good marker of CKD-MBD; however, meta-analyses in human medicine have shown poor correlation between other markers of CKD-MBD and mortality. 22 Furthermore, multiple studies have also demonstrated a stronger relationship with mortality between FGF-23 than other markers of CKD-MBD. [23] [24] [25] This combined data implies there might be an association between FGF-23 and death that extends beyond dysregulation in CKD-MBD. In people,
there is a strong correlation between FGF-23 and cardiovascular death, but this has not been extensively studied in veterinary medicine. 23 Another explanation is that FGF-23 is a marker of reduced GFR and advanced CKD. Thereby, the increases in FGF-23 levels are an indicator of advancement and progression of CKD.
Lastly, there is limited evidence that FGF-23 might have a directly toxic effect on the body that might affect survival. 24, 26 However, this In this study, a thin BCS and muscle atrophy at the time of diagnosis were significantly associated with shorter survival. This is similar to results from studies of people and dogs with CKD. 9,27-29 Hypoalbuminemia also was significantly associated with survival, similar to people with CKD and previous reports of dogs. 9, [29] [30] [31] Similarly, proteinuria, CaPP, and hyperphosphatemia were associated with greater hazard ratios and decreased survival, related to mechanisms described elsewhere. [12] [13] [14] [32] [33] [34] [35] [36] PTH, iCa and vitamin D metabolites were not associated with survival in this study, contrary to previous reports for some of these variables in dogs and humans. 6, 7, 13 Importantly, when analyzing the data on non-significant variables in this study, it is useful to look at the frequency at which dogs were outside the established reference ranges. In each of these categories, only a few dogs were outside the cut-off points for reference ranges. As a result, the statistical analysis was not robust enough to detect potential differences in the groups based on these variables. A larger study should be conducted with more dogs with each of these abnormalities to assess their association with survival.
There were a number of limitations in this study. Dogs were enrolled in various stages of the disease as they were presented to the teaching hospital. All-cause mortality was used in this survival analysis, and as the majority of dogs in this study were euthanized, 
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